122 related articles for article (PubMed ID: 8544726)
1. [Synthetic oligonucleotides and their application in gene therapy].
Iribarren AM
Medicina (B Aires); 1995; 55(3):263-6. PubMed ID: 8544726
[TBL] [Abstract][Full Text] [Related]
2. Not nonsense but antisense--applications of antisense oligonucleotides in different fields of medicine.
Oberbauer R
Wien Klin Wochenschr; 1997 Jan; 109(2):40-6. PubMed ID: 9123943
[TBL] [Abstract][Full Text] [Related]
3. Antisense strategy in hematological malignancies.
Warzocha K
Cytokines Cell Mol Ther; 1999 Mar; 5(1):15-23. PubMed ID: 10390076
[TBL] [Abstract][Full Text] [Related]
4. [Antisense oligonucleotides are clinically tested. They inhibit the expression of disease-related genes].
Sommer W; Heilig M
Lakartidningen; 1999 Jan; 96(4):348-54. PubMed ID: 10024826
[TBL] [Abstract][Full Text] [Related]
5. Antisense oligonucleotides as therapeutics for malignant diseases.
Ho PT; Parkinson DR
Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
[TBL] [Abstract][Full Text] [Related]
6. [Antisense oligonucleotides: a new therapeutic approach].
Guinot P; Temsamani J
Pathol Biol (Paris); 1998 May; 46(5):347-54. PubMed ID: 9769897
[TBL] [Abstract][Full Text] [Related]
7. [Basics of antisense oligonucleotide therapy and current therapeutical strategies in urology].
Kausch I; Böhle A
Aktuelle Urol; 2003 Dec; 34(7):458-68. PubMed ID: 14655082
[TBL] [Abstract][Full Text] [Related]
8. Gene technology: chances for diagnosis and therapy.
Werner RG
Methods Find Exp Clin Pharmacol; 1994 Sep; 16(7):525-37. PubMed ID: 7885080
[TBL] [Abstract][Full Text] [Related]
9. Antisense therapy in the treatment of hypercholesterolemia.
Lippi G; Favaloro EJ
Eur J Intern Med; 2011 Dec; 22(6):541-6. PubMed ID: 22075277
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic applications of genetic engineering].
Descamps JL
Ann Pharm Fr; 1994; 52(6):294-302. PubMed ID: 7864529
[TBL] [Abstract][Full Text] [Related]
11. Antisense oligonucleotides strategy in the treatment of hypertension.
Kagiyama S; Kagiyama T; Phillips MI
Curr Opin Mol Ther; 2001 Jun; 3(3):258-64. PubMed ID: 11497350
[TBL] [Abstract][Full Text] [Related]
12. Antisense oligonucleotides as therapeutic agents.
Galderisi U; Cascino A; Giordano A
J Cell Physiol; 1999 Nov; 181(2):251-7. PubMed ID: 10497304
[TBL] [Abstract][Full Text] [Related]
13. Molecular therapy to inhibit NFkappaB activation by transcription factor decoy oligonucleotides.
Morishita R; Tomita N; Kaneda Y; Ogihara T
Curr Opin Pharmacol; 2004 Apr; 4(2):139-46. PubMed ID: 15063357
[TBL] [Abstract][Full Text] [Related]
14. Antisense oligonucleotide therapy in cancer.
Stephens AC; Rivers RP
Curr Opin Mol Ther; 2003 Apr; 5(2):118-22. PubMed ID: 12772500
[TBL] [Abstract][Full Text] [Related]
15. ISIS 301012 gene therapy for hypercholesterolemia: sense, antisense, or nonsense?
Ito MK
Ann Pharmacother; 2007 Oct; 41(10):1669-78. PubMed ID: 17848425
[TBL] [Abstract][Full Text] [Related]
16. Antisense oligonucleotides: towards clinical trials.
Agrawal S
Trends Biotechnol; 1996 Oct; 14(10):376-87. PubMed ID: 8987636
[TBL] [Abstract][Full Text] [Related]
17. [Antisense oligonucleotides: a new class of biologically active molecules].
Uteshev DB; Korostelev SA; Sergeev AV; Uteshev BS
Eksp Klin Farmakol; 2004; 67(3):76-9. PubMed ID: 15341077
[TBL] [Abstract][Full Text] [Related]
18. Antisense therapy in malignant diseases: status quo and quo vadis?
Tamm I
Clin Sci (Lond); 2006 Apr; 110(4):427-42. PubMed ID: 16526947
[TBL] [Abstract][Full Text] [Related]
19. Antisense molecules for targeted cancer therapy.
Wacheck V; Zangemeister-Wittke U
Crit Rev Oncol Hematol; 2006 Jul; 59(1):65-73. PubMed ID: 16750913
[TBL] [Abstract][Full Text] [Related]
20. A hitchhiker's guide to antisense and nonantisense biochemical pathways.
Branch AD
Hepatology; 1996 Dec; 24(6):1517-29. PubMed ID: 8938189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]